دورية أكاديمية
أعرض في EDS

Gaps in glucagon fills among commercially insured patients receiving a glucagon prescription.

التفاصيل البيبلوغرافية
العنوان: Gaps in glucagon fills among commercially insured patients receiving a glucagon prescription.
المؤلفون: Herges JR; Department of Pharmacy, Mayo Clinic, Rochester, MN, United States. Electronic address: Herges.Joseph@mayo.edu., Haag JD; Department of Pharmacy, Mayo Clinic, Rochester, MN, United States. Electronic address: Haag.Jordan@mayo.edu., Kosloski-Tarpenning KA; Department of Pharmacy, Mayo Clinic Health System, Southeast Minnesota Region, Owatonna, MN, United States. Electronic address: Tarpenning.Kimberly@mayo.edu., Mara KC; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, United States. Electronic address: Mara.Kristin@mayo.edu., McCoy RG; Division of Community Internal Medicine, Geriatrics, and Palliative Care, Mayo Clinic, Rochester, MN, United States. Electronic address: McCoy.Rozalina@mayo.edu.
المصدر: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2023 Jun; Vol. 200, pp. 110720. Date of Electronic Publication: 2023 May 16.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8227 (Electronic) Linking ISSN: 01688227 NLM ISO Abbreviation: Diabetes Res Clin Pract Subsets: MEDLINE
أسماء مطبوعة: Publication: 1993- : Limerick : Elsevier Scientific Publishers
Original Publication: Amsterdam : Elsevier Science Publishers B.V., c1985-
مواضيع طبية MeSH: Glucagon*/therapeutic use , Diabetes Mellitus*/drug therapy, Humans ; United States ; Retrospective Studies ; Prescriptions
مستخلص: Glucagon is critically underutilized, and we explored whether this is due to inadequate glucagon prescribing or the patient's inability to fill prescriptions. Of 216 commercially insured, high-risk individuals with diabetes who were prescribed glucagon in our healthcare system, 142 (65.4%) had a claim indicating its fill within 30 days.
Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: In the last 36 months, Dr. McCoy has received support from NIDDK, National Institute on Aging (NIA) of the NIH, Patient Centered Outcomes Research Institute (PCORI), National Center for Advancing Translational Sciences (NCATS), and AARP® for unrelated work. She also served as a consultant to Emmi® (Wolters Kluwer) on developing patient education materials related to diabetes.
(Copyright © 2023 Elsevier B.V. All rights reserved.)
References: Diabetol Metab Syndr. 2022 Dec 23;14(1):193. (PMID: 36550552)
Diabetes Care. 2023 Mar 1;46(3):620-627. (PMID: 36630526)
J Diabetes Complications. 2021 May;35(5):107882. (PMID: 33593689)
JAMA Netw Open. 2022 Aug 1;5(8):e2229428. (PMID: 36040744)
JAMA Intern Med. 2021 Oct 1;181(10):1412-1414. (PMID: 34228043)
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. (PMID: 36507646)
Endocr Pract. 2016 Feb;22(2):123-35. (PMID: 26484405)
Diabet Med. 2023 Jun;40(6):e15084. (PMID: 36924085)
Endocrine. 2019 May;64(2):233-238. (PMID: 30367442)
معلومات مُعتمدة: K23 DK114497 United States DK NIDDK NIH HHS
فهرسة مساهمة: Keywords: Diabetes; Glucagon; Hypoglycemia
المشرفين على المادة: 9007-92-5 (Glucagon)
تواريخ الأحداث: Date Created: 20230517 Date Completed: 20230606 Latest Revision: 20240603
رمز التحديث: 20240603
مُعرف محوري في PubMed: PMC10278149
DOI: 10.1016/j.diabres.2023.110720
PMID: 37196705
قاعدة البيانات: MEDLINE
الوصف
تدمد:1872-8227
DOI:10.1016/j.diabres.2023.110720